Absolute abundance and function of intestinal drug transporters: a prerequisite for fully mechanistic in vitro-in vivo extrapolation of oral drug absorption (Q38038547)

From Wikidata

Jump to navigation Jump to search

scientific article published on 08 October 2012

Language	Label	Description	Also known as
English	Absolute abundance and function of intestinal drug transporters: a prerequisite for fully mechanistic in vitro-in vivo extrapolation of oral drug absorption	scientific article published on 08 October 2012

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

Absolute abundance and function of intestinal drug transporters: a prerequisite for fully mechanistic in vitro-in vivo extrapolation of oral drug absorption (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

author name string

M D Harwood

1

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

S Neuhoff

2

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

G L Carlson

3

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

G Warhurst

4

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

A Rostami-Hodjegan

5

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

publication date

8 October 2012

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

Biopharmaceutics and Drug Disposition

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

34

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

2-28

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

PBPK as a tool in regulatory review

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1810

21 January 2018

An industrial perspective on contemporary applications of PBPK models in drug discovery and development

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1810

21 January 2018

Membrane transporters in drug development

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1810

21 January 2018

Oral modified-release formulations in motion: the relationship between gastrointestinal transit and drug absorption

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1810

21 January 2018

The drug transporter-metabolism alliance: uncovering and defining the interplay

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1810

21 January 2018

Efflux and uptake transporters as determinants of statin response.

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1810

21 January 2018

Modeling of intestinal drug absorption: roles of transporters and metabolic enzymes (for the Gillette Review Series).

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1810

21 January 2018

Prediction of pharmacokinetics prior to in vivo studies. 1. Mechanism-based prediction of volume of distribution.

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1810

21 January 2018

Mechanistic approaches to volume of distribution predictions: understanding the processes.

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1810

21 January 2018

A framework for assessing inter-individual variability in pharmacokinetics using virtual human populations and integrating general knowledge of physical chemistry, biology, anatomy, physiology and genetics: A tale of 'bottom-up' vs 'top-down' recogn

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1810

21 January 2018

The Simcyp population-based ADME simulator

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1810

21 January 2018

Population-based mechanistic prediction of oral drug absorption

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1810

21 January 2018

Simulations of the nonlinear dose dependence for substrates of influx and efflux transporters in the human intestine

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1810

21 January 2018

Interplay of metabolism and transport in determining oral drug absorption and gut wall metabolism: a simulation assessment using the "Advanced Dissolution, Absorption, Metabolism (ADAM)" model.

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1810

21 January 2018

Utility of intersystem extrapolation factors in early reaction phenotyping and the quantitative extrapolation of human liver microsomal intrinsic clearance using recombinant cytochromes P450.

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1810

21 January 2018

Physiologically-Based Pharmacokinetics in Drug Development and Regulatory Science

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1810

21 January 2018

Transporter-mediated drug-drug interactions

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1810

21 January 2018

Intestinal permeability and its relevance for absorption and elimination

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1810

21 January 2018

Targeting intestinal transporters for optimizing oral drug absorption

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1810

21 January 2018

Evidence for intestinal secretion as an additional clearance pathway of talinolol enantiomers: concentration- and dose-dependent absorption in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1810

21 January 2018

Assessment of the pharmacokinetics, safety and tolerability of maraviroc, a novel CCR5 antagonist, in healthy volunteers

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1810

21 January 2018

Potential of novel antiretrovirals to modulate expression and function of drug transporters in vitro

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1810

21 January 2018

Pharmacokinetics of the acyclovir pro-drug valaciclovir after escalating single- and multiple-dose administration to normal volunteers

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1810

21 January 2018

Identification of the rate-determining process in the hepatic clearance of atorvastatin in a clinical cassette microdosing study.

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1810

21 January 2018

Cytochrome P450-mediated metabolism in the human gut wall

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1810

21 January 2018

Intestinal UGTs as potential modifiers of pharmacokinetics and biological responses to drugs and xenobiotics

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1810

21 January 2018

Quantitative evaluation of the expression and activity of five major sulfotransferases (SULTs) in human tissues: the SULT "pie".

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1810

21 January 2018

Intestinal transporters for endogenic and pharmaceutical organic anions: the challenges of deriving in-vitro kinetic parameters for the prediction of clinically relevant drug-drug interactions

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1810

21 January 2018

Caco-2 monolayers in experimental and theoretical predictions of drug transport

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1810

21 January 2018

Refining the in vitro and in vivo critical parameters for P-glycoprotein, [I]/IC50 and [I2]/IC50, that allow for the exclusion of drug candidates from clinical digoxin interaction studies

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1810

21 January 2018

Pharmaceutical drug transport: the issues and the implications that it is essentially carrier-mediated only

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1810

21 January 2018

Expression of thirty-six drug transporter genes in human intestine, liver, kidney, and organotypic cell lines.

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1810

21 January 2018

Models to predict unbound intracellular drug concentrations in the presence of transporters

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1810

21 January 2018

Identification of novel specific and general inhibitors of the three major human ATP-binding cassette transporters P-gp, BCRP and MRP2 among registered drugs.

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1810

21 January 2018

Impact of extracellular protein binding on passive and active drug transport across Caco-2 cells.

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1810

21 January 2018

Absolute quantification of multidrug resistance-associated protein 2 (MRP2/ABCC2) using liquid chromatography tandem mass spectrometry

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1810

21 January 2018

Liquid chromatography/tandem mass spectrometry based targeted proteomics quantification of P-glycoprotein in various biological samples

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1810

21 January 2018

Development of a new permeability assay using low-efflux MDCKII cells.

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1810

21 January 2018

Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1810

21 January 2018

Are MDCK cells transfected with the human MDR1 gene a good model of the human intestinal mucosa?

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1810

21 January 2018

Efflux ratio cannot assess P-glycoprotein-mediated attenuation of absorptive transport: asymmetric effect of P-glycoprotein on absorptive and secretory transport across Caco-2 cell monolayers

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1810

21 January 2018

Bias in estimation of transporter kinetic parameters from overexpression systems: Interplay of transporter expression level and substrate affinity.

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1810

21 January 2018

Effect of P-glycoprotein expression levels on the concentration-dependent permeability of drugs to the cell membrane

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1810

21 January 2018

Structure of P-glycoprotein reveals a molecular basis for poly-specific drug binding

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1810

21 January 2018

Decrease in intracellular concentration causes the shift in Km value of efflux pump substrates.

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1810

21 January 2018

Neurotransmitter transporters: molecular function of important drug targets

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1810

21 January 2018

Mechanisms of pH-gradient driven transport mediated by organic anion polypeptide transporters

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1810

21 January 2018

In silico modeling for the nonlinear absorption kinetics of UK-343,664: a P-gp and CYP3A4 substrate.

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1810

21 January 2018

Kinetic considerations for the quantitative assessment of efflux activity and inhibition: implications for understanding and predicting the effects of efflux inhibition.

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1810

21 January 2018

Model analysis of the concentration-dependent permeability of P-gp substrates

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1810

21 January 2018

Mechanisms underlying saturable intestinal absorption of metformin

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1810

21 January 2018

Estimation of Michaelis-Menten constant of efflux transporter considering asymmetric permeability

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1810

21 January 2018

Effects of experimental setup on the apparent concentration dependency of active efflux transport in in vitro cell permeation experiments.

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1810

21 January 2018

A catenary model to study transport and conjugation of baicalein, a bioactive flavonoid, in the Caco-2 cell monolayer: demonstration of substrate inhibition.

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1810

21 January 2018

Physiologically based pharmacokinetic modeling 1: predicting the tissue distribution of moderate-to-strong bases.

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1810

21 January 2018

Growth factor- and adhesion protein-like components of fetal calf serum can significantly enhance the intracellular delivery of Peptide nucleic acids.

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1810

21 January 2018

Physiologically based pharmacokinetic (PBPK) modelling tools: how to fit with our needs?

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1810

21 January 2018

Transport approaches to the biopharmaceutical design of oral drug delivery systems: prediction of intestinal absorption

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1810

21 January 2018

Saturable small intestinal drug absorption in humans: modeling and interpretation of cefatrizine data

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1810

21 January 2018

Scaling factors for the extrapolation of in vivo metabolic drug clearance from in vitro data: reaching a consensus on values of human microsomal protein and hepatocellularity per gram of liver.

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1810

21 January 2018

Interindividual variability in hepatic expression of the multidrug resistance-associated protein 2 (MRP2/ABCC2): quantification by liquid chromatography/tandem mass spectrometry

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1810

21 January 2018

Sex-dependent expression and activity of the ATP-binding cassette transporter breast cancer resistance protein (BCRP/ABCG2) in liver

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1810

21 January 2018

Transporter pharmacogenetics and statin toxicity

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1810

21 January 2018

MDR1 pharmacogenetics: frequency of the C3435T mutation in exon 26 is significantly influenced by ethnicity

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1810

21 January 2018

The role of intestinal P-glycoprotein in the interaction of digoxin and rifampin

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1810

21 January 2018

Effect of variations in the amounts of P-glycoprotein (ABCB1), BCRP (ABCG2) and CYP3A4 along the human small intestine on PBPK models for predicting intestinal first pass.

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1810

21 January 2018

Mapping of multidrug resistance gene 1 and multidrug resistance-associated protein isoform 1 to 5 mRNA expression along the human intestinal tract

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1810

21 January 2018

Expression of the drug transporters MDR1/ABCB1, MRP1/ABCC1, MRP2/ABCC2, BCRP/ABCG2, and PXR in peripheral blood mononuclear cells and their relationship with the expression in intestine and liver

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1810

21 January 2018

Variability in mRNA expression of ABC- and SLC-transporters in human intestinal cells: comparison between human segments and Caco-2 cells.

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1810

21 January 2018

The effect of rifampin treatment on intestinal expression of human MRP transporters

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1810

21 January 2018

Intestinal expression of P-glycoprotein (ABCB1), multidrug resistance associated protein 2 (ABCC2), and uridine diphosphate-glucuronosyltransferase 1A1 predicts the disposition and modulates the effects of the cholesterol absorption inhibitor ezetim

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1810

21 January 2018

Distribution of breast cancer resistance protein (BCRP/ABCG2) mRNA expression along the human GI tract

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1810

21 January 2018

Breast cancer resistance protein (ABCG2) and drug disposition: intestinal expression, polymorphisms and sulfasalazine as an in vivo probe

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1810

21 January 2018

Consequences of bile duct obstruction on intestinal expression and function of multidrug resistance-associated protein 2.

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1810

21 January 2018

Gene and protein expression of P-glycoprotein, MRP1, MRP2, and CYP3A4 in the small and large human intestine.

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1810

21 January 2018

Sources of interindividual variability in IVIVE of clearance: an investigation into the prediction of benzodiazepine clearance using a mechanistic population-based pharmacokinetic model

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1810

21 January 2018

Predicting drug clearance from recombinantly expressed CYPs: intersystem extrapolation factors

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1810

21 January 2018

Isotope dilution strategies for absolute quantitative proteomics

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1810

21 January 2018

Quantitative targeted absolute proteomics-based ADME research as a new path to drug discovery and development: methodology, advantages, strategy, and prospects.

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1810

21 January 2018

Absolute difference of hepatobiliary transporter multidrug resistance-associated protein (MRP2/Mrp2) in liver tissues and isolated hepatocytes from rat, dog, monkey, and human.

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1810

21 January 2018

LC-MS/MS mediated absolute quantification and comparison of bile salt export pump and breast cancer resistance protein in livers and hepatocytes across species.

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1810

21 January 2018

Simultaneous absolute protein quantification of transporters, cytochromes P450, and UDP-glucuronosyltransferases as a novel approach for the characterization of individual human liver: comparison with mRNA levels and activities.

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1810

21 January 2018

Expression of ABC-type transport proteins in human platelets

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1810

21 January 2018

Absolute quantification and differential expression of drug transporters, cytochrome P450 enzymes, and UDP-glucuronosyltransferases in cultured primary human hepatocytes

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1810

21 January 2018

Transcriptomic and quantitative proteomic analysis of transporters and drug metabolizing enzymes in freshly isolated human brain microvessels

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1810

21 January 2018

Quantitative membrane protein expression at the blood-brain barrier of adult and younger cynomolgus monkeys.

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1810

21 January 2018

Quantitative proteomics of transporter expression in brain capillary endothelial cells isolated from P-glycoprotein (P-gp), breast cancer resistance protein (Bcrp), and P-gp/Bcrp knockout mice

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1810

21 January 2018

In vitro evaluation of hepatic transporter-mediated clinical drug-drug interactions: hepatocyte model optimization and retrospective investigation

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1810

21 January 2018

Development of a highly sensitive method using liquid chromatography-multiple reaction monitoring to quantify membrane P-glycoprotein in biological matrices and relationship to transport function

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1810

21 January 2018

Development of a multiplex UPLC-MRM MS method for quantification of human membrane transport proteins OATP1B1, OATP1B3 and OATP2B1 in in vitro systems and tissues

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1810

21 January 2018

Localization of P-gp (Abcb1) and Mrp2 (Abcc2) in freshly isolated rat hepatocytes

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1810

21 January 2018

Comparative evaluation of current peptide production platforms used in absolute quantification in proteomics

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1810

21 January 2018

Comparison of five commercial extraction kits for subsequent membrane protein profiling

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1810

21 January 2018

Inter-individual variability in levels of human microsomal protein and hepatocellularity per gram of liver

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1810

21 January 2018

Cytochrome P450 3A4 and P-glycoprotein expression in human small intestinal enterocytes and hepatocytes: a comparative analysis in paired tissue specimens

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1810

21 January 2018

Efflux transporters in ulcerative colitis: decreased expression of BCRP (ABCG2) and Pgp (ABCB1).

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1810

21 January 2018

Dimerization and actin-bundling properties of villin and its role in the assembly of epithelial cell brush borders

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1810

21 January 2018

Role of the breast cancer resistance protein (ABCG2) in drug transport

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1810

21 January 2018

Characterization of drug transport, ATP hydrolysis, and nucleotide trapping by the human ABCG2 multidrug transporter. Modulation of substrate specificity by a point mutation

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1810

21 January 2018

The membrane lipid environment modulates drug interactions with the P-glycoprotein multidrug transporter

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1810

21 January 2018

Interaction of verapamil with lipid membranes and P-glycoprotein: connecting thermodynamics and membrane structure with functional activity

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1810

21 January 2018

Comparison of the gastrointestinal anatomy, physiology, and biochemistry of humans and commonly used laboratory animals

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1810

21 January 2018

H/dipeptide absorption across the human intestinal epithelium is controlled indirectly via a functional Na/H exchanger.

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1810

21 January 2018

Characterization of the regional intestinal kinetics of drug efflux in rat and human intestine and in Caco-2 cells

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1810

21 January 2018

Investigation of regional mechanisms responsible for poor oral absorption in humans of a modified release preparation of the alpha-adrenoreceptor antagonist, 4-amino-6,7-dimethoxy-2-(5-methanesulfonamido-1,2,3,4 tetrahydroisoquinol-2-yl)-5-(2-pyridy

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1810

21 January 2018

ATP-dependent transport of organic anions into isolated basolateral membrane vesicles from rat intestine

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1810

21 January 2018

Disulfide cross-linking analysis shows that transmembrane segments 5 and 8 of human P-glycoprotein are close together on the cytoplasmic side of the membrane

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1810

21 January 2018

Multichannel liquid chromatography-tandem mass spectrometry cocktail method for comprehensive substrate characterization of multidrug resistance-associated protein 4 transporter

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1810

21 January 2018

Investigation of the rate-determining process in the hepatic elimination of HMG-CoA reductase inhibitors in rats and humans

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1810

21 January 2018

A novel screening strategy to identify ABCB1 substrates and inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1810

21 January 2018

Metabolic and Efflux Properties of Caco-2 Cells Stably Transfected with Nuclear Receptors

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1810

21 January 2018

Multiplexed absolute quantification for proteomics using concatenated signature peptides encoded by QconCAT genes

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1810

21 January 2018

Identifiers

10.1002/BDD.1810

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38038547&oldid=1738273496"